Patterns of occurrence and implications of neratinib-associated diarrhea in patients with HER2-positive breast cancer: analyses from the randomized phase III ExteNET trial.
Joanne E MortimerJack Di PalmaKendra SchmidYining YeMohammad JahanzebPublished in: Breast cancer research : BCR (2019)
ClinicalTrials.gov NCT00878709. Registered 9 April 2009.